Overview

A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to use imaging technologies to demonstrate the effects of teriparatide on bone structure following 18 to 24 months of therapy in postmenopausal women with osteoporosis.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Teriparatide